Investorideas.com
Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 


Investorideas podcasts on iTunes, Google Play Music and iHeart.com    Bitcoin and Blockchain Stocks    8020 Connect

 

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Pennsylvania Health Department Approves Allowing Patients to Vaporize Whole Plant Marijuana Flowers, Adding Qualifying Conditions to Program

Changes would increase scope of patients who can find relief with medical marijuana, decrease cost to patients, and help alleviate product shortages

 

HARRISBURG, Pa. - April 16, 2018 (Investorideas.com Newswire) At a hearing on Monday, the Department of Health approved changes to the Pennsylvania medical marijuana program that were recommended by the Medical Marijuana Advisory Board on April 9.

The Department approved the advisory board's recommendations to allow patients to access medical marijuana flowers for vaporization in addition to the more expensive processed products they can currently obtain from dispensaries. Smoking marijuana would remain prohibited. It also approved several additions to the list of conditions for which patients can qualify for the program.

The Department of Health will promulgate official regulations with the changes on May 12.

Medical marijuana became available in Pennsylvania to registered patients in February. Only a fraction of the approved cultivation centers and dispensaries are currently operational, and patients are not permitted to purchase whole plant marijuana under the current system. This has led to product shortages and prohibitively expensive medicine throughout the state. There is more information about the benefits to patients of allowing whole plant marijuana here.

"Allowing cannabis in its natural, flower form and expanding the list of qualifying conditions will have a huge positive impact on seriously ill Pennsylvanians," said Becky Dansky, legislative counsel for the Marijuana Policy Project, who helped lead the medical marijuana effort in the state legislature. "By being able to provide medical marijuana in plant form, producers will be able to get medicine into the hands of patients much more quickly and for much lower cost to patients. This is vitally important for patient access right now while the program is still getting off the ground and production is not yet at full capacity. We hope these rules are promulgated as quickly as possible so even more patients will be able to find relief."

Pennsylvania was the 24th state to pass and implement an effective medical marijuana law. There are 29 states with effective medical marijuana laws and more than a dozen states have had medical marijuana bills introduced this year.

The Marijuana Policy Project is the nation's largest marijuana policy organization. For more information, visit http://www.MarijuanaPolicy.org.



Marijuana / Hemp Stocks

Marijuana / Hemp Stocks

At Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news


More Info:

Investorideas.com Newswire

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.